These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 35105621)
1. FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder. Chen Y; Xueying Z; Jiaqu C; Qiyi C; Huanlong Q; Ning L; Yasong D; Xiaoxin Z; Rong Y; Jubao L; Xiaoqiong L; Chunlian M; Yu W; Shidong C; Guifang K; Dongmei Z; Shuanfeng F; Xujing Z; Binrang Y; Yanxia W; Ling L; Song Y; Xiang Z; Beihua Z; Lin J; Hong J; BMJ Open; 2022 Jan; 12(1):e051613. PubMed ID: 35105621 [TBL] [Abstract][Full Text] [Related]
2. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial. Pai N; Popov J; Hill L; Hartung E BMJ Open; 2019 Nov; 9(11):e030120. PubMed ID: 31784432 [TBL] [Abstract][Full Text] [Related]
3. Protocol for the Gut Bugs in Autism Trial: a double-blind randomised placebo-controlled trial of faecal microbiome transfer for the treatment of gastrointestinal symptoms in autistic adolescents and adults. Tweedie-Cullen RY; Leong K; Wilson BC; Derraik JGB; Albert BB; Monk R; Vatanen T; Creagh C; Depczynski M; Edwards T; Beck K; Thabrew H; O'Sullivan JM; Cutfield WS BMJ Open; 2024 Feb; 14(2):e074625. PubMed ID: 38320845 [TBL] [Abstract][Full Text] [Related]
4. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study. Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial. Hoffmann-Vold AM; Fretheim HH; Sarna VK; Barua I; Carstens MN; Distler O; Khanna D; Volkmann ER; Midtvedt Ø; Didriksen H; Dhainaut A; Halse AK; Bakland G; Pesonen M; Olsen I; Molberg Ø BMJ Open; 2021 Jun; 11(6):e048541. PubMed ID: 34168032 [TBL] [Abstract][Full Text] [Related]
6. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607 [TBL] [Abstract][Full Text] [Related]
7. Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial. Skjevling L; Goll R; Hanssen HM; Johnsen PH BMJ Open; 2024 Jun; 14(6):e073275. PubMed ID: 38858151 [TBL] [Abstract][Full Text] [Related]
8. Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial. Pai N; Popov J BMJ Open; 2017 Aug; 7(8):e016698. PubMed ID: 28827258 [TBL] [Abstract][Full Text] [Related]
9. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078 [TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Li N; Chen H; Cheng Y; Xu F; Ruan G; Ying S; Tang W; Chen L; Chen M; Lv L; Ping Y; Chen D; Wei Y Front Cell Infect Microbiol; 2021; 11():759435. PubMed ID: 34737978 [TBL] [Abstract][Full Text] [Related]
11. Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy. Kang DW; Adams JB; Vargason T; Santiago M; Hahn J; Krajmalnik-Brown R mSphere; 2020 Oct; 5(5):. PubMed ID: 33087514 [TBL] [Abstract][Full Text] [Related]
12. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial. Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848 [TBL] [Abstract][Full Text] [Related]
13. Protocol for the safety and efficacy of fecal microbiota transplantation liquid in children with autism spectrum disorder: a randomized controlled study. Wei J; Chen J; Fang X; Liu T; Yuan Y; Zhang J Front Microbiol; 2023; 14():1236904. PubMed ID: 37675433 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial. Kragsnaes MS; Kjeldsen J; Horn HC; Munk HL; Pedersen FM; Holt HM; Pedersen JK; Holm DK; Glerup H; Andersen V; Fredberg U; Kristiansen K; Christensen R; Ellingsen T BMJ Open; 2018 Apr; 8(4):e019231. PubMed ID: 29703851 [TBL] [Abstract][Full Text] [Related]
17. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents. Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929 [TBL] [Abstract][Full Text] [Related]
18. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Ng SC; Xu Z; Mak JWY; Yang K; Liu Q; Zuo T; Tang W; Lau L; Lui RN; Wong SH; Tse YK; Li AYL; Cheung K; Ching JYL; Wong VWS; Kong APS; Ma RCW; Chow EYK; Wong SKH; Ho ICH; Chan PKS; Chan FKL Gut; 2022 Apr; 71(4):716-723. PubMed ID: 33785557 [TBL] [Abstract][Full Text] [Related]
19. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Stallmach A; Grunert P; Stallhofer J; Löffler B; Baier M; Rödel J; Kiehntopf M; Neugebauer S; Pieper DH; Junca H; Tannapfel A; Merkel U; Schumacher U; Breternitz-Gruhne M; Heller T; Schauer A; Hartmann M; Steube A Trials; 2022 Feb; 23(1):173. PubMed ID: 35193638 [TBL] [Abstract][Full Text] [Related]
20. Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol. Hanssen HM; Fjellstad MS; Skjevling L; Johnsen PH; Kulseng B; Goll R; Almå KH; Valle PC BMJ Open; 2023 Dec; 13(12):e073242. PubMed ID: 38151280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]